Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Clin Monit Comput ; 37(1): 63-70, 2023 02.
Article in English | MEDLINE | ID: mdl-35429325

ABSTRACT

The risk of pulmonary complications is high after major abdominal surgery but may be reduced by prophylactic postoperative noninvasive ventilation using continuous positive airway pressure (CPAP). This study compared the effects of intermittent mask CPAP (ICPAP) and continuous helmet CPAP (HCPAP) on oxygenation and the risk of pulmonary complications following major abdominal surgery. Patients undergoing open abdominal aortic aneurysm repair or pancreaticoduodenectomy were randomized (1:1) to either postoperative ICPAP or HCPAP. Oxygenation was evaluated as the partial pressure of oxygen in arterial blood fraction of inspired oxygen ratio (PaO2/FIO2) at 6 h, 12 h, and 18 h postoperatively. Pulmonary complications were defined as X-ray verified pneumonia/atelectasis, clinical signs of pneumonia, or supplementary oxygen beyond postoperative day 3. Patient-reported comfort during CPAP treatment was also evaluated. In total, 96 patients (ICPAP, n = 48; HCPAP, n = 48) were included, and the type of surgical procedure were evenly distributed between the groups. Oxygenation did not differ between the groups by 6 h, 12 h, or 18 h postoperatively (p = 0.1, 0.08, and 0.67, respectively). Nor was there any difference in X-ray verified pneumonia/atelectasis (p = 0.40) or supplementary oxygen beyond postoperative day 3 (p = 0.53). Clinical signs of pneumonia tended to be more frequent in the ICPAP group (p = 0.06), yet the difference was not statistically significant. Comfort scores were similar in both groups (p = 0.43), although a sensation of claustrophobia during treatment was only experienced in the HCPAP group (11% vs. 0%, p = 0.03). Compared with ICPAP, using HCPAP was associated with similar oxygenation (i.e., PaO2/FIO2 ratio) and a similar risk of pulmonary complications. However, HCPAP treatment was associated with a higher sensation of claustrophobia.


Subject(s)
Pneumonia , Pulmonary Atelectasis , Humans , Continuous Positive Airway Pressure/adverse effects , Continuous Positive Airway Pressure/methods , Postoperative Complications/prevention & control , Postoperative Complications/etiology , Oxygen , Pulmonary Atelectasis/complications , Pulmonary Atelectasis/prevention & control , Pneumonia/prevention & control
2.
Eur J Gastroenterol Hepatol ; 29(4): 400-406, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27926661

ABSTRACT

BACKGROUND: Capillary leakage, secondary to endothelial breakdown, is common in patients undergoing major surgical procedures with extensive tissue injury and this is associated with increased morbidity and mortality. Prostacyclin has been ascribed cytoprotective properties together with its vasodilatory and antiplatelet effects. The present pilot study investigated the safety and endothelial protective effects of low-dose prostacyclin infusion. PATIENTS AND METHODS: A randomized placebo-controlled pilot study evaluating the effect of prostacyclin (iloprost) infusion (1.0 ng/kg/min) versus placebo (saline infusion) intraoperatively and 6 h postoperatively in patients undergoing a pancreaticoduodenoctemy was carried out. Hemodynamics were evaluated by Nexfin, hemostasis was evaluated by thrombelastography, and transfusion requirements were registered. Endothelial damage was evaluated by circulating sE-selectin, soluble thrombomodulin, and nucleosomes. RESULTS: Comparable baseline demography and surgical time were found. Hemodynamics were comparable between groups. The placebo group received more red blood cells, median 115 ml [interquartile range (IQR): 0-296 ml] versus 0 ml (IQR: 0-0 ml), P=0.027, at the postoperative ward and after 6 h. Thrombelastography maximum clot firmness decreased intraoperatively only in the placebo group (P=0.034)). Soluble thrombomodulin increased more in the placebo group postoperatively [1.63 ng/ml (IQR: 0.65-2.55 ng/ml) versus 0.40 ng/ml (IQR: 0.21-0.63 ng/ml), P=0.027] and 6 h postoperatively [1.83 (1.1-2.36) versus 0.67 (0.42-0.91), P=0.027]. Nucleosomes increased intraoperatively and postoperatively only in the placebo group; thus, the overall level of nucleosomes was higher in the placebo group (P=0.019). CONCLUSION: Intraoperative and postoperative low-dose prostacyclin infusion is safe and associated with reduced endothelial cell damage in patients undergoing a pancreaticoduodenoctemy compared with those receiving placebo.


Subject(s)
Endothelium, Vascular/drug effects , Epoprostenol/pharmacology , Hemodynamics/drug effects , Hemostasis/drug effects , Pancreaticoduodenectomy/methods , Aged , Biomarkers/blood , Blood Transfusion/methods , Cytoprotection , Drug Administration Schedule , Duodenal Neoplasms/surgery , Epoprostenol/administration & dosage , Female , Fluid Therapy/methods , Humans , Infusions, Intravenous , Male , Middle Aged , Pancreatic Neoplasms/surgery , Perioperative Care/methods , Pilot Projects , Thrombelastography/methods
3.
Ugeskr Laeger ; 176(15)2014 Apr 07.
Article in Danish | MEDLINE | ID: mdl-25350146

ABSTRACT

A mesenteric traction syndrome manifests in some patients undergoing major abdominal surgery and is identified by flushing, accompanied by hypotension and tachycardia. We used laser speckle contrast imaging to quantify blood flow in forehead skin of patients undergoing Whipple's operation. In two patients with similar blood pressure (-50 mmHg) and profound drop in systemic vascular resistance (-40%), forehead skin perfusion increased three-fold in one patient, while it was unchanged in a patient for whom flushing was not evident.


Subject(s)
Flushing/diagnosis , Hypotension/diagnosis , Tachycardia/diagnosis , Aged , Blood Flow Velocity/physiology , Female , Flushing/drug therapy , Flushing/physiopathology , Humans , Hypotension/drug therapy , Hypotension/physiopathology , Lasers , Male , Microcirculation/physiology , Monitoring, Intraoperative/methods , Pancreatic Neoplasms/surgery , Syndrome , Tachycardia/drug therapy , Tachycardia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...